High concentration of human lactoferrin in milk of rhLf-transgenic cows relieves signs of bovine experimental Staphylococcus chromogenes intramammary infection

Veterinary Immunology and Immunopathology

Volumn 136, Issue 3-4, 2010, Pages 265-271

  Simojoki, Heli ^a   Hyvönen, Paula ^b   Orro, Toomas ^c   Pyörälä, Satu ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c ESTONIAN UNIVERSITY OF LIFE SCIENCES   (Estonia)

Author keywords

Bovine; CNS; Intramammary infection; Lactoferrin; Mastitis; Staphylococcus chromogenes; Transgenesis

Indexed keywords

AMYLOID A PROTEIN; ANTIINFECTIVE AGENT; LACTOFERRIN; N ACETYL BETA GLUCOSAMINIDASE; RECOMBINANT HUMAN LACTOFERRIN; UNCLASSIFIED DRUG; ACETYLGLUCOSAMINIDASE; SERUM AMYLOID A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE MASTITIS; CIRCULATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROL GROUP; CONTROLLED STUDY; MILK; NONHUMAN; STAPHYLOCOCCUS; STAPHYLOCOCCUS CHROMOGENES; STAPHYLOCOCCUS INFECTION; TRANSGENIC ANIMAL; TRANSGENIC CATTLE; ANIMAL; ANIMAL DISEASE; CATTLE; CELL COUNT; CYTOLOGY; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOLOGY; LACTATION; MICROBIOLOGY; STATISTICAL MODEL;

BOVINAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS CHROMOGENES;

ACETYLGLUCOSAMINIDASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CATTLE; CELL COUNT; FEMALE; HUMANS; LACTATION; LACTOFERRIN; LINEAR MODELS; MASTITIS, BOVINE; MILK; SERUM AMYLOID A PROTEIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 77958179975     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.03.017     Document Type: Article

References (48)

1. Aarestrup F.M., Wegener H.C., Rosdahl V.T., Jensen N.E. Staphylococcal and other bacterial species associated with intramammary infections in Danish dairy herds. Acta Vet. Scand. 1995, 36:475-487.
2. Aguila A., Herrera A.G., Morrison D., Cosgrove B., Perojo A., Montesinos I., Perez J., Sierra G., Gemmell C.G., Brock J.H. Bacteriostatic activity of human Lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance. FEMS Immunol. Med. Microbiol. 2001, 31:145-152.
3. Anderson K.L., Smith A.R., Shanks R.D., Davis L.E., Gustafsson B.K. Efficacy of flunixin meglumine for the treatment of endotoxin-induced bovine mastitis. Am. J. Vet. Res. 1986, 47:1366-1372.
4. Appelmelk B.J., An Y.Q., Geerts M., Thijs B.G., de Boer H.A., MacLaren D.M., de G.J., Nuijens J.H. Lactoferrin is a lipid A-binding protein. Infect. Immun. 1994, 62:2628-2632.
5. Borm A.A., Fox L.K., Leslie K.E., Hogan J.S., Andrew S.M., Moyes K.M., Oliver S.P., Schukken Y.H., Hancock D.D., Gaskins C.T., Owens W.E., Norman C. Effects of prepartum intramammary antibiotic therapy on udder health, milk production, and reproductive performance in dairy heifers. J. Dairy Sci. 2006, 89:2090-2098.
6. Brink M.F., Bishop M.D., Pieper F.R. Developing efficient strategies for the generation of transgenic cattle which produce biopharmaceuticals in milk. Theriogenology 2000, 53:139-148.
7. Brock J.H. The Physiology of lactoferrin. Biochem. Cell Biol. 2002, 80:1-6.
8. Burvenich C., Van Merris V., Mehrzad J., Diez-Fraile A., Duchateau L. Severity of E. Coli mastitis is mainly determined by cow factors. Vet. Res. 2003, 34:521-564.
9. Chaneton L., Tirante L., Maito J., Chaves J., Bussmann L.E. Relationship between milk lactoferrin and etiological agent in the mastitic bovine mammary gland. J. Dairy Sci. 2008, 91:1865-1873.
10. Diarra M.S., Petitclerc D., Deschenes E., Lessard N., Grondin G., Talbot B.G., Lacasse P. Lactoferrin against Staphylococcus aureus mastitis lactoferrin alone or in combination with penicillin G on bovine polymorphonuclear function and mammary epithelial cells colonisation by Staphylococcus aureus. Vet. Immunol. Immunopathol. 2003, 95:33-42.
11. Diarra M.S., Petitclerc D., Lacasse P. Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis. J. Dairy Sci. 2002, 85:1141-1149.
12. Hagiwara S., Kawai K., Anri A., Nagahata H. Lactoferrin concentrations in milk from normal and subclinical mastitic cows. J. Vet. Med. Sci. 2003, 65:319-323.
13. Hogan J.S., González R.N., Harmon R.J., Nickerson S.C., Oliver S.P., Smith K.L., Pankey J.W. Laboratory Handbook on Bovine Mastitis 1999, The National Mastitis Counc., Madison WI. Rev Ed.
14. Hyvönen P., Käyhkö S., Taponen S., von Wright A., Pyörälä S. Effect of bovine lactoferrin on the internalization of coagulase-negative staphylococci into bovine mammary epithelial cells under in-vitro conditions. J. Dairy Res. 2009, 1-8.
15. Hyvönen P., Suojala L., Haaranen J., von W.A., Pyörälä S. Human and bovine lactoferrins in the milk of recombinant human lactoferrin-transgenic dairy cows during lactation. Biotechnol. J. 2006, 1:410-412.
16. Hyvönen P., Suojala L., Orro T., Haaranen J., Simola O., Røntved C., Pyörälä S. Transgenic cows that produce recombinant human lactoferrin in milk are not protected from experimental Escherichia coli intramammary infection. Infect. Immun. 2006, 74:6206-6212.
17. Kai K., Komine K., Komine Y., Kuroishi T., Kozutsumi T., Kobayashi J., Ohta M., Kitamura H., Kumagai K. Lactoferrin stimulates a Staphylococcus aureus killing activity of bovine phagocytes in the mammary gland. Microbiol. Immunol. 2002, 46:187-194.
18. Kai K., Komine Y., Komine K., Asai K., Kuroishi T., Kozutsumi T., Itagaki M., Ohta M., Kumagai K. Effects of bovine lactoferrin by the intramammary infusion in cows with staphylococcal mastitis during the early non-lactating period. J. Vet. Med. Sci. 2002, 64:873-878.
19. Kawai K., Nagahata H., Lee N.Y., Anri A., Shimazaki K. Effect of infusing lactoferrin hydrolysate into bovine mammary glands with subclinical mastitis. Vet. Res. Commun. 2003, 27:539-548.
20. Kawai K., Shimazaki K., Higuchi H., Nagahata H. Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils. Zoonoses. Public Health 2007, 54:160-164.
21. Kerr D.E., Wellnitz O. Mammary expression of new genes to combat mastitis. J. Anim. Sci. 2003, 81(Suppl. 3):38-47.
22. Kitchen B.J., Middleton G., Salmon M. Bovine milk N-acetyl-beta-d-glucosaminidase and its significance in detection of abnormal udder secretions. J. Dairy Res. 1978, 45:15-20.
23. Komine K., Komine Y., Kuroishi T., Kobayashi J., Obara Y., Kumagai K. Small molecule lactoferrin with an inflammatory effect but no apparent antibacterial activity in mastitic mammary gland secretion. J. Vet. Med. Sci. 2005, 67:667-677.
24. Komine Y., Komine K., Kai K., Itagaki M., Kuroishi T., Aso H., Obara Y., Kumagai K. Effect of combination therapy with lactoferrin and antibiotics against staphylococcal mastitis on drying cows. J. Vet. Med. Sci. 2006, 68:205-211.
25. Krimpenfort P., Rademakers A., Eyestone W., van der S.A., van den B.S., Kooiman P., Kootwijk E., Platenburg G., Pieper F., Strijker R. Generation of transgenic dairy cattle using 'in vitro' embryo production. Biotechnology (N.Y.) 1991, 9:844-847.
26. Kutila T., Pyörälä S., Saloniemi H., Kaartinen L. Antibacterial effect of bovine lactoferrin against udder pathogens. Acta Vet. Scand. 2003, 44:35-42.
27. Kutila T., Suojala L., Lehtolainen T., Saloniemi H., Kaartinen L., Tähti M., Seppalä K., Pyörälä S. The Efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis. J. Vet. Pharmacol. Ther. 2004, 27:197-202.
28. Lacasse P., Lauzon K., Diarra M.S., Petitclerc D. Utilization of lactoferrin to fight antibiotic resistant mammary gland pathogens. J. Anim. Sci. 2008, 86:66-71.
29. Leitch E.C., Willcox M.D. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J. Med. Microbiol. 1999, 48:867-871.
30. Leitch E.C., Willcox M.D. Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Curr. Eye Res. 1999, 19:12-19.
31. Matthews K.R., Harmon R.J., Langlois B.E. Effect of naturally-occurring coagulase-negative staphylococci infections on new infections by mastitis pathogens in the bovine. J. Dairy Sci. 1991, 74:1855-1859.
32. Mattila T., Sandholm M. Antitrypsin and N-acetyl-beta-d-glucosaminidase as markers of mastitis in a herd of ayshire cows. Am. J. Vet. Res. 1985, 46:2453-2456.
33. Nibbering P.H., Ravensbergen E., Welling M.M., van Berkel L.A., van Berkel P.H., Pauwels E.K., Nuijens J.H. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 2001, 69:1469-1476.
34. Nuijens J.H., van Berkel P.H., Schanbacher F.L. Structure and biological actions of lactoferrin. J. Mammary Gland Biol. Neoplasia 1996, 1:285-295.
35. Patel D., Almeida R.A., Dunlap J.R., Oliver S.P. Bovine lactoferrin serves as a molecular bridge for internalization of Streptococcus uberis into bovine mammary epithelial cells. Vet. Microbiol. 2009.
36. Petitclerc D., Lauzon K., Cochu A., Ster C., Diarra M.S., Lacasse P. Efficacy of a lactoferrin-penicillin combination to treat β-lactam-resistant Staphylococcus aureus mastitis. J. Dairy Sci. 2007, 90:2778-2787.
37. Pinheiro J., Bates D., DebRoy S., Sarkar D. nlme Linear and Nonlinear Mixed Effects Models. R-package version 3.1-73 2006, Department of Statistics and Mathematics, Wirtschafts Universität Wien, Wien, http://www.r-project.org.
38. Pitkälä A., Haveri M., Pyörälä S., Myllys V., Honkanen-Buzalski T. Bovine mastitis in Finland 2001-prevalence, distribution of bacteria, and antimicrobial resistance. J. Dairy Sci. 2004, 87:2433-2441.
39. Pyörälä S., Taponen S. Coagulase-negative staphylococci-emerging mastitis pathogens. Vet. Microbiol. 2009, 134:3-8.
40. Rainard P., Riollet C. Innate immunity of the bovine mammary gland. Vet. Res. 2006, 37:369-400.
41. Taponen S., Koort J., Björkroth J., Saloniemi H., Pyörälä S. Bovine intramammary infections caused by coagulase-negative staphylococci may persist throughout lactation according to amplified fragment length polymorphism-based analysis. J. Dairy Sci. 2007, 90:3301-3307.
42. Taponen S., Simojoki H., Haveri M., Larsen H.D., Pyörälä S. Clinical characteristics and persistence of bovine mastitis caused by different species of coagulase-negative staphylococci identified with API or AFLP. Vet. Microbiol. 2006, 115:199-207.
43. Tenhagen B.A., Koster G., Wallmann J., Heuwieser W. Prevalence of mastitis pathogens and their resistance against antimicrobial agents in dairy cows in Brandenburg, Germany. J. Dairy Sci. 2006, 89:2542-2551.
44. Thomassen E.A.J., van Veen H.A., van Berkel P.H.C., Nuijens J.H., Abrahams J.P. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin. Transgenic Res. 2005, 14:397-405.
45. van Berkel P.H., van Veen H.A., Geerts M.E., de Boer H.A., Nuijens J.H. Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants. Biochem. J. 1996, 319(Pt 1):117-122.
46. van Berkel P.H.C., Welling M.M., Geerts M., van Veen H.A., Ravensbergen B., Salaheddine M., Pauwels E.K.J., Pieper F., Nuijens J.H., Nibbering P.H. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat. Biotechnol. 2002, 20:484-487.
47. Wall R.J., Powell A.M., Paape M.J., Kerr D.E., Bannerman D.D., Pursel V.G., Wells K.D., Talbot N., Hawk H.W. Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat. Biotechnol. 2005, 23:445-451.
48. Weinberg E.D. Suppression of bacterial biofilm formation by iron limitation. Med. Hypotheses 2004, 63:863-865.